Omega Healthcare Investors (NYSE:OHI - Get Free Report) had its price objective decreased by equities researchers at Wells Fargo & Company from $43.00 to $41.00 in a research note issued on Monday,Benzinga reports. The firm currently has an "overweight" rating on the real estate investment trust's stock. Wells Fargo & Company's target price indicates a potential upside of 8.48% from the stock's previous close.
Several other equities research analysts have also recently weighed in on the company. BMO Capital Markets raised Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price target for the company in a research note on Monday, December 9th. Royal Bank of Canada raised their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a report on Monday, November 11th. JMP Securities reaffirmed a "market perform" rating on shares of Omega Healthcare Investors in a research note on Friday, February 7th. Finally, Mizuho increased their price objective on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a research report on Thursday, December 5th. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $41.44.
Read Our Latest Stock Analysis on OHI
Omega Healthcare Investors Trading Up 2.5 %
OHI traded up $0.91 during trading on Monday, reaching $37.80. 108,033 shares of the company's stock were exchanged, compared to its average volume of 2,006,259. The company has a current ratio of 7.07, a quick ratio of 7.07 and a debt-to-equity ratio of 1.02. Omega Healthcare Investors has a one year low of $29.66 and a one year high of $44.42. The firm has a fifty day moving average price of $37.11 and a two-hundred day moving average price of $39.00. The stock has a market capitalization of $10.65 billion, a PE ratio of 24.38, a price-to-earnings-growth ratio of 1.09 and a beta of 1.00.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 EPS for the quarter, topping analysts' consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a net margin of 38.65% and a return on equity of 9.71%. As a group, equities research analysts forecast that Omega Healthcare Investors will post 2.86 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Omega Healthcare Investors
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC grew its stake in shares of Omega Healthcare Investors by 3.1% in the 3rd quarter. Geode Capital Management LLC now owns 6,426,129 shares of the real estate investment trust's stock valued at $261,589,000 after buying an additional 192,465 shares during the period. State Street Corp boosted its holdings in Omega Healthcare Investors by 0.9% in the third quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust's stock worth $502,228,000 after acquiring an additional 114,085 shares in the last quarter. Assetmark Inc. grew its stake in Omega Healthcare Investors by 2.9% in the fourth quarter. Assetmark Inc. now owns 1,225,923 shares of the real estate investment trust's stock valued at $46,401,000 after acquiring an additional 34,463 shares during the period. Tallon Kerry Patrick bought a new stake in shares of Omega Healthcare Investors during the fourth quarter valued at approximately $1,250,000. Finally, BNP Paribas Financial Markets raised its position in shares of Omega Healthcare Investors by 120.8% during the third quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust's stock worth $9,212,000 after purchasing an additional 123,836 shares during the period. 65.25% of the stock is owned by institutional investors.
About Omega Healthcare Investors
(
Get Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
